Skip to main content

Tekla Capital Management LLC

SEC CIK
0001300336
Latest filing
Aug 10, 2023

CRL holding history

Charles River Laboratories International, Inc. in every 13F filed by Tekla Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRL overviewAll 13F holders of CRLFull Q2 2023 holdings

Shares (Q2 2023)
111,183
Value
$23.4M
% of portfolio
0.9%
Quarters held
10
Since Q1 2021
Holdings of CRL by Tekla Capital Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2023111,183$23.4M0.9%−6,900−5.8%ReducedHolders
Q1 2023118,083$23.8M0.9%+45,408+62.5%AddedHolders
Q4 202272,675$15.8M0.6%00.0%UnchangedHolders
Q3 202272,675$14.3M0.6%+24,781+51.7%AddedHolders
Q2 202247,894$10.2M0.4%−14,096−22.7%ReducedHolders
Q1 202261,990$17.6M0.6%00.0%UnchangedHolders
Q4 202161,990$23.4M0.8%−16,494−21.0%ReducedHolders
Q3 202178,484$32.4M1.0%+23,810+43.5%AddedHolders
Q2 202154,674$20.2M0.7%+11,600+26.9%AddedHolders
Q1 202143,074$12.5M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.